Merit Financial Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Sell |
14,713
-202
| -1% | -$25.6K | 0.02% | 551 |
|
|
2025
Q1 | $1.91M | Sell |
14,915
-2,041
| -12% | -$261K | 0.03% | 431 |
|
|
2024
Q4 | $2.24M | Sell |
16,956
-824
| -5% | -$109K | 0.04% | 331 |
|
|
2024
Q3 | $2.59M | Buy |
17,780
+620
| +4% | +$90.3K | 0.06% | 243 |
|
|
2024
Q2 | $2.36M | Sell |
17,160
-310
| -2% | -$42.6K | 0.05% | 249 |
|
|
2024
Q1 | $2.32M | Buy |
+17,470
| New | +$2.32M | 0.06% | 243 |
|
|
2023
Q4 | – | Sell |
-5,357
| Closed | -$655K | – | 796 |
|
|
2023
Q3 | $655K | Sell |
5,357
-23,604
| -82% | -$2.89M | 0.02% | 396 |
|
|
2023
Q2 | $3.68M | Sell |
28,961
-366
| -1% | -$46.5K | 0.12% | 131 |
|
|
2023
Q1 | $3.79M | Sell |
29,327
-1,355
| -4% | -$175K | 0.14% | 111 |
|
|
2022
Q4 | $4.03M | Sell |
30,682
-1,019
| -3% | -$134K | 0.15% | 103 |
|
|
2022
Q3 | $3.71M | Sell |
31,701
-2,439
| -7% | -$285K | 0.16% | 81 |
|
|
2022
Q2 | $4.02M | Buy |
34,140
+3,265
| +11% | +$384K | 0.12% | 100 |
|
|
2022
Q1 | $4.02M | Buy |
+30,875
| New | +$4.02M | 0.24% | 63 |
|